Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Generate Biomedicines, Inc.
GENB
Free cash flow margin
Free cash flow margin at other companies
Semtech
SMTC
15.9%
+7.7pp
Nucor
NUE
5.6%
-11.5pp
Northern Trust
NTRS
65.1%
-24.5pp
Dycom Industries
DY
7%
+6.1pp
Nordson
NDSN
24.6%
+7.6pp
Berkshire Hathaway
BRK.A
6.4%
—
Other financials
Income statement
See full
Revenue
$6.3M
-37.7%
Operating income
-$71.6M
-19.1%
Net income
-$67.3M
-28.3%
EPS (diluted)
-$0.52
+73.2%
Balance sheet
See full
Cash & equivalents
$135.4M
-12.3%
Total debt
$62.6M
—
Total equity
$456.0M
+188%
Total assets
$561.7M
—
Cash flow
See full
Operating cash flow
-$57.9M
-18.9%
CapEx
$933.0K
+506%
Free cash flow
-$58.9M
-20.4%
Valuation
See full
Market cap
$1.86B
+19.8%
Enterprise value
$1.78B
—
P/S
57.2×
—
Profitability
See full
Operating margin
-751.2%
—
Net margin
-685.9%
—
Returns & leverage
See full
Return on equity
2,979.4%
—
Debt / equity
0.1×
—
Current ratio
8.3×
—
Watchlist
Screener
Filings
Earnings
Charts